XRF Scientific (XRF) H1 2025 earnings summary

Executive summary

• Revenue for the half-year ended 31 December 2024 was $28.7m, up slightly from $28.6m year-over-year.

• Net profit attributable to equity holders rose to $5.0m from $4.5m year-over-year.

• Acquisitions of Labfit and the remaining 50% of Orbis Mining expanded product offerings and market reach.

• The group operates in three segments: Capital Equipment, Precious Metals, and Consumables.

Financial highlights

• Gross profit increased to $13.5m from $12.4m year-over-year.

• Profit before income tax was $6.9m, up from $6.3m year-over-year.

• Basic and diluted EPS rose to 3.6 cents from 3.3 cents year-over-year.

• Cash and cash equivalents decreased to $8.1m from $12.0m at 30 June 2024.

• Dividends paid during the half-year totaled $5.4m, up from $4.5m year-over-year.

Outlook and guidance

• Labfit acquisition expected to contribute positively in the second half as initial loss reverses with invoiced sales.

• Orbis Mining acquisition anticipated to enhance group profitability and revenue diversification.